why choose us

First received: August 17, 2022

Clinical Trial: A Phase III Randomized, Modified Double-blind, Multi-centric, Comparative Study, to Evaluate the Non-inferiority of Immunogenicity and Safety of Hillchol® (BBV131)to Shanchol™ Along With Lot-to-lot Consistency of Hillchol®(BBV131).

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Cholera

Study Type: Interventional


Official Title: A Phase III Randomized, Modified Double-blind, Multi-centric, Comparative Study, to Evaluate the Non-inferiority of Immunogenicity and Safety of Single Strain Oral Cholera Vaccine Hillchol® (BBV131)to

Brief Summary: A Phase III randomized, modified double-blind, multi-centric, comparative study, to evaluate the noninferiority of immunogenicity and safety of single strain oral cholera vaccine Hillchol® (BBV131) to the comparator vaccine Shanchol™ along with lot-to-lot consistency of Hillchol® (BBV131).Study Population: A total of 1800 participants will be enrolled in three descending age groups (Group I- >18, Group II: > 5 to 1 to

Read more